News Hub | News Direct

Lifestyle

Beverage: Coffee/Tea/Non-Alcoholic Beverage: Spirits/Beer/Wine Casino/Gaming Fashion Food/Cooking/Baking Health & Fitness Home Goods Hospitality Leisure Activities & Hobbies Parenting Pets Photography Seniors Travel & Tourism
Article thumbnail News Release

Detecting Early Signs of Heart Disease

YourUpdateTV

One in five people worldwide have inherited high lipoprotein(a) and most don’t know it. Because high Lp(a) isn’t screened for, often the first sign of this condition can be a heart attack or stroke. There are more than 60 million people in the United States at high risk for a heart attack or stroke because they were born with high lipoprotein(a). Recently, Katherine Wilemon, founder and CEO of the Family Heart Foundation, teamed up with preventive cardiologist Dr. Seth Baum, chief scientific officer of Flourish Research, on a nationwide satellite media tour to raise awareness and encourage people to get screened. A video accompanying this announcement is available at: https://youtu.be/NGQBZxqF-GI Lp(a) is a cholesterol-like substance that is unrelated to the food you eat or how you live. People inherit Lp(a) levels from their parents and high levels of Lp(a) significantly increase your likelihood of having a heart attack or stroke. High Lp(a) is a "triple threat" as it can clog your arteries like LDL cholesterol but it also promotes inflammation and increases the risk of your blood clotting. If you have heart disease or have had a stroke, or someone in your family has experienced cardiovascular disease, it is important to get screened for high Lp(a). In addition, if your LDL cholesterol is very high — over 190 mg/dL —you should also have your Lp(a) tested. Research from the Family Heart Foundation revealed that fewer than 1% of Americans had ever had their lipoprotein(a) tested – and it’s a simple blood test. “The truth is with 20% of the population affected, and heart disease continuing to be the single biggest threat to one’s ability to live a long healthy life, everyone should be screened,” said Dr. Baum. The Family Heart Foundation declared March 24 Lp(a) Awareness Day to raise awareness worldwide. In its second year, this day draws attention to high Lp(a) as an under-recognized cause of premature heart disease and stroke. “March 24 is a perfect time for everyone to think about their family history, be screened for high Lp(a) and maybe change the future for millions of Americans,” said Wilemon. For more information, visit FamilyHeart.org. The Family Heart Foundation’s Care Navigation team can answer questions and connect you to a healthcare provider near you. About Katherine Wilemon On the month she turned 39 years old, Katherine Wilemon’s world was rocked by a heart attack caused by a complete artery blockage. It was the importance of family that drove Katherine to investigate the deeper physiological issues that contributed to her cardiac event. She learned that she had familial hypercholesterolemia (FH), and, years later, that she also had elevated levels of lipoprotein(a). The more Katherine advocated for herself, the more she encountered an inadequate understanding of genetic conditions such as FH. Always an entrepreneur, she founded the Family Heart Foundation in 2011 to increase early diagnosis and treatment. Over the years the Foundation has helped create a national research registry for FH, established diagnostic codes and consensus statements for care, and provided a community for those living with inherited cholesterol disorders. Now, the organization has expanded to drive awareness and scientific understanding of Lp(a) so that others with high levels can better protect themselves and their families. About Seth Baum, MD, FACC, FACPM, FAHA, FNLA, FASPC Dr. Seth J. Baum is Chief Scientific Officer at Flourish Research, and clinical affiliate professor of Cardiology at FAU Medical School. He actively consults in Clinical Lipidology and Cardiovascular Disease Prevention and continues to offer lipoprotein apheresis for patients in southeast and central Florida. Dr. Baum has practiced Preventive Cardiology and Clinical Lipidology since 2000. He is a fellow of the American College of Cardiology, the American Heart Association, the American College of Preventive Medicine, the National Lipid Association, and the American Society for Preventive Cardiology. Dr. Baum is a past President of the American Society for Preventive Cardiology (ASPC). He currently serves on both the ASPC and Family Heart Foundation Advisory Boards. He has published over 100 peer reviewed papers and abstracts as well as two books. In 2013, he was awarded Cleveland Heart Lab’s “Heart Award” for lifelong dedication to Preventive Medicine. In 2019, Dr. Baum received Mended Hearts’ biennial Dwight Emary Harken Award. Dr. Baum is the Founder of Excel Medical Clinical Trials, LLC, a consortium of clinicians dedicated to the safe and professional conduct of high-level scientific trials. He has served as Principal Investigator in over 100 clinical trials covering a broad range of disease states. Dr. Baum is the Chief Scientific Officer of Flourish Research, a leading national clinical research company. Dr. Baum is a graduate of Columbia College and Columbia College of Physicians and Surgeons, and completed training in Internal Medicine, Cardiology, Interventional Cardiology, and Electrophysiology. Contact Details YourUpdateTV +1 212-736-2727 yourupdatetv@gmail.com

March 22, 2023 09:19 AM Eastern Daylight Time

Video
Article thumbnail News Release

What Is Autologous Cell-Based Therapy, The Treatment Revolutionizing Regenerative Medicine That Could Be Set To Explode Over The Next Few Years?

BioRestorative Therapies, Inc.

By Julian Richard, Benzinga Successful Autologous Cell-Based Therapies The global CAR-T cell therapy market is growing continuously due to novel clinical and commercial developments in this therapy. As a result, the Global CAR-T cell therapy market is expected to be worth USD 4.36 billion by 2028 from 2.31 billion in 2023, growing with a healthy CAGR of 13.5% during the forecast period. Companies like Pfizer (NYSE: PFE) Johnson & Johnson (NYSE: JNJ, Bristol-Meyers Squibb (NYSE: BMY) as well as Gilead Sciences (NASDAQ: GILD) all are focusing on this innovative CAR-T cell therapy. Autologous cell based therapies are personalized therapies using your own cells to target a disease or disorder. Personalized therapies targeting cancer such CAR-T cell therapies have generated impressive clinical results with complete remission rates in B-acute lymphoblastic leukemia in over >80% of patients. One of the reasons this therapy has been successful is because it is autologous. In 2017, the U.S. FDA approved the first two CAR-T cell therapies: Novartis’ Kymriah ® for treatment of acute lymphoblastic leukemia (ALL) and Gilead subsidiary Kite Pharma’s Yescarta ® for certain types of large B-cell lymphomas, a type of non-Hodgkin lymphoma. These autologous therapies are patient-specific where the therapeutic CAR-T cells are created from a patient’s own cells. The Value of Autologous Stem-Cell Therapies Autologous stem-cell therapy is a novel medical technology that is revolutionizing the way the medical community approaches the treatment of metabolic, autoimmune and degenerative diseases. Additionally, this technique has been used successfully to develop skin grafts for wound care, treat burns and bedsores and speed up recovery after surgery. The method involves extracting stem cells from a patient’s body and culturing them in laboratory conditions before reintroducing them into the patient. Stem cells are a unique type of cell that can develop into any other cell in the body. These “supercharged” cells can be used for tissue regeneration and repair, making stem cells a potent tool in modern personalized medicine. Stratified medicine simply cannot compete with this customization, precision, and safety profile. The main benefit of using autologous cells is that these cells come from your own body and therefore do not trigger any immunological rejection reactions. They also minimize the risk of infection from non-patient sources. This allows autologous cell therapy to be used safely over a longer term, ensuring that the patient can access consistent and reliable treatment without risk of rejection or complications due to incompatibility. In 2021, the autologous cell therapy market was valued at $4.3 billion and was projected to skyrocket to $29.1 billion by 2031—marking a compounded annual growth rate (CAGR) of 21% from 2022-2031. Although the market is still nascent, it is expected to eventually create a new healthcare sector with revenue similar to that of the pharmaceutical, biotechnological, and medical devices industries. An Autologous Stem Cell-Based Approach to treat Disc Pain BioRestorative Therapies Inc (NASDAQ: BRTX) focuses on innovative “home-grown” autologous stem-cell therapies to address unmet needs in patients with common yet serious diseases. It was founded by medical doctors, scientists and world-renowned stem-cell researchers committed to developing novel stem-cell therapies. The lead candidate in BioRestorative’s musculoskeletal stem-cell platform is BRTX-100, administered as a minimally-invasive single intradiscal injection. BRTX-100 is currently being evaluated in an FDA gold standard phase 2 double-blind, controlled, randomized study in those with chronic lumbar disc disease (cLDD). Chronic lumbar disc disease affects over 500 million individuals globally and is currently only treatable with opioids and surgery. Despite being the most commonly prescribed drug for cLLD, no clinical data supports the use of opioids in cLLD, which only serves to increase the opioid crisis in the USA. Surgery for cLLD carries many disadvantages and limitations. The cost of surgery can be high. While surgical intervention may reduce pain in some cases, it often fails to restore previous levels of function or mobility. Revision or reoperation rates for surgical intervention in the spine can be upwards of 20-30% of the cases performed. Furthermore, a more extended recovery period is associated with an increased risk of mechanical instability of the spine and potentially increased failure rates compared to non-surgical treatments. It would appear a bright future awaits BioRestorative Therapies and the autologous cell therapy market in general as patients increasingly look at personalized alternatives to surgery and conventional medicine. BRTX-100 is an innovative and minimally-invasive technology set to revolutionize lower back pain treatment. Visit https://www.biorestorative.com for more information on the company and its product candidates. This article was originally published on Benzinga here. BioRestorative Therapies was founded by scientists and researchers committed to developing stem cell therapies to address unmet needs in patients with highly prevalent conditions.Our advances in stem cell biology and delivery protocols harbor great promise in conditioning our bodies’ own regenerative potential to treat major diseases more effectively than current interventions.Today, BioRestorative is actively developing programs that aim to dramatically increase quality of care for both (i) chronic back pain caused by disc degeneration, as well as (ii) metabolic disorders including obesity and diabetes. This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Investor Relations ir@biorestorative.com Company Website https://www.biorestorative.com/

March 22, 2023 09:15 AM Eastern Daylight Time

Article thumbnail News Release

Global Wellness Company Fine Hygienic Holding Launches eon Longevity, an All-Natural Herbal Longevity Supplement

Fine Hygienic Holding

Fine Hygienic Holding (FHH), one of the world’s leading wellness groups, today announced the launch of eon ™, a powdered, herbal beverage supplement that supports overall health and longevity. Comprising an all-natural, proprietary herbal blend, eon Longevity +Plus (eon’s signature product) underwent one of the largest clinical studies in the supplement space. The results verified that eon supports the health of the cardiovascular, respiratory, and gastrointestinal systems; regulates normal metabolic balance; and helps reduce inflammation — all of which result in a healthier and stronger body. One of the most impactful findings is eon’s ability to reduce inflammation, which is a breakthrough since inflammation is at the core of most, if not all, diseases in the human body. “With these outstanding clinical results, it can be argued that eon could be the healthiest beverage a person can consume and should be part of everyone’s personal wellness program to improve quality of life and even life expectancy,” said Medical Wellness Association (MWA) President Dr. Christopher Breuleux, who underwrote the clinical study. “We are a company devoted to improving people’s health and lives by providing reliable, tested, high-quality products,” said eon Founder and FHH President of Wellness Elia G. Nuqul. “We are extremely happy to finally make this amazing product available after more than 3.5 years of hard work. The biggest reward in all this is knowing we have something that can really improve people’s health and lives, and unlock their longevity at an affordable price.” eon is the first FHH product to be fully procured, manufactured, packaged and launched in the U.S. The beverage supplement has also been professionally certified by the MWA. FHH CEO James Michael Lafferty said, “eon reduces total body inflammation, resulting in significant health benefits. You will not find a modern drug using these powerful ingredients to battle inflammation, which is often linked to conditions such as cancer, heart disease, diabetes, asthma, and Alzheimer's disease.” Inspired by Tea from the Mediterranean The inspiration behind eon’s innovation came from a viral video viewed by Lafferty and Nuqul. It featured a centenarian man youthfully navigating his village, climbing trees, and attributing his long and healthy life to his herbal tea. Captivated by this video, Nuqul embarked on an international sojourn to locate the elder gentleman and learn directly about the drink that kept him so spry. After studying, modifying, and enhancing the tea with the MWA, eon is the result. “eon is a beautiful marriage of nature and science. The ingredients of this beverage supplement have been tested independently and proven to have significant health benefits, most notably in the battle of inflammation and the systemic problems it causes,” added Lafferty. “Here was this centenarian living a healthy and full life attributed to drinking this drink, so we asked ourselves: What if the root to longevity is in the Mediterranean — and what if this benefit was available to everyone for the same price as a cup of coffee?” Clinical Study Results The clinical study, underwritten by the Medical Wellness Association, was one of the largest ever in the wellness supplement industry. Each participant consumed the beverage daily, all under medical supervision. The clinical trials scientifically proved, with statistical significance, that the consumption of eon Longevity +Plus yielded a range of health benefits, including: Reduces and controls inflammation and pain, a breakthrough since inflammation is at the core of most, if not all, diseases in the human body Supports cardiovascular and respiratory health Powerful source of antioxidants Regulates normal metabolic syndrome and improves gastrointestinal (gut) health Improves kidney and liver function (*amongst a subset of the clinical study) Reduces pre-diabetes risk factors Reduces stress Improves mood, vitality and sleep eon Now Available In addition to the clinically proven eon Longevity +Plus (which includes the highly bioavailable curcumin), customers also have access to eon Longevity, which is the all-natural herbal proprietary blend inspired by the centenarian man (without the curcumin). For best results, consume either blend at least once daily mixed with warm or cold water on an empty stomach. It may also be added to other beverages such as coffee or tea. The beverage supplement is only available as individual stick packs online at www.eon-longevity.com. About eonThe eon Longevity Blends™ are all-natural, herbal beverage supplements inspired by a generations-old formula and created by nature. Through one of the largest clinical studies conducted in the supplement space, eon Longevity +Plus (eon’s signature product) has been scientifically proven to provide significant health benefits when consumed at least once a day, especially through the reduction of inflammation. eon is part of Fine Hygienic Holding, one of the world’s leading wellness groups. More at www.eon-longevity.com. About Fine Hygienic HoldingFine Hygienic Holding (FHH), one of the world’s leading wellness groups and MENA’s leading manufacturer of hygienic products, serves consumers in more than 80 countries around the world. Originally established as a paper manufacturer, FHH has transformed into a wellness company dedicated to enhancing global health and wellbeing. Committed to becoming “the shining star of the Arab FMCG business world,” the Group focuses on wellness, sustainability, pioneering CSR programs, and state-of-the-art production processes. Fine Hygienic Holding offers a diverse array of award-winning products, including sterilized facial tissues, napkins, kitchen towels, toilet paper, baby diapers, adult briefs, jumbo rolls. It also offers away-from-home products to accommodate all types of private and public institutions in addition to its advanced range of personal protective equipment and long-lasting germ protection solutions. FHH also brings Nai natural iced teas and innovative nutritional supplements, such as eon and Motiva, to the market. Contact Details Rana Kawalit | │ Corporate Communication & PR Director +971 54 531 5575 Rkawalit@finehh.com Company Website https://www.finehh.com/

March 21, 2023 05:20 PM Eastern Daylight Time

Article thumbnail News Release

Traveling on a Budget in 2023

YourUpdateTV

While prices for flights, hotels and rental cars are all up across the board, demand for travel isn’t slowing. A recent survey from pay over time provider, Affirm, revealed that despite record-high costs, the average person plans to take three trips this year and spend over $3,000 on travel. Furthermore, 3 in 4 of Millennial and Gen-Z respondents plan to take up to 6 trips this year, with over half planning to spend up to $5,000 on travel. Traveling on a budget can help ensure that people are spending responsibly while also providing ways to make their money go further. Affirm SVP and Financial Health Expert, Katrina Holt, participated in a nationwide satellite media tour, offering her top tips for financially-conscious travelers in 2023: Don’t forget to set a budget. The recent Affirm survey found that nearly 1 in 5 plan to travel this year without setting a budget beforehand, which can easily lead to overspending. When creating a budget, be sure to consider expenses across accommodation, meals, transportation and shopping. Use a transparent, flexible pay over time option like Affirm to spread out your costs and stick to your budget. By selecting Affirm at checkout, approved travelers can split travel costs into biweekly or monthly payments. Travelers will see the total cost of their purchase and will never pay more than they agree to upfront Affirm does not charge late or hidden fees. Watch out for gimmicks that come with travel credit cards. Early sign up bonuses might be enticing, but can easily lead to overspending as you try to hit the minimum. 0% APR credit card promotions can come with deferred interest and surprise you with balloon payments down the line. A video accompanying this announcement is available at: https://youtu.be/2ZCQtGXL7y8 Affirm is helping travelers by offering a smarter way to pay at some of the largest travel merchants in the US and Canada, including American Airlines, Expedia, Hotels.com, KAYAK, Vrbo, Priceline, and more. For more information, visit Affirm.com About Katrina Holt Katrina Holt is the SVP, Operations and Financial Health Expert at Affirm. Affirm is a new kind of payment network — one based on trust, transparency and putting people first. As a technology and financial services executive, Katrina brings more than 27 years of financial services, operations, and risk management leadership. Prior to Affirm, she was the Chief Compliance Officer at GE Capital Bank and WebBank, respectively. Earlier in her career, Katrina served as the Audit Director for GE Capital, as well as a commissioned bank examiner with the FDIC. She holds an Executive MBA from the University of Utah and a BS in Accounting from Weber State University. Contact Details YourUpdateTV +1 212-736-2727 yourupdatetv@gmail.com

March 21, 2023 02:30 PM Eastern Daylight Time

Video
Article thumbnail News Release

Aqua Cultured Foods to Begin Consumer Tastings of Alt-Seafood

AquaCultured Foods

Food tech startup Aqua Cultured Foods today announced it will begin consumer tastings of its seafood alternatives at its Chicago facility in advance of launching publicly through chef partners and foodservice distributors. Aqua will offer participants Aqua tuna rolls, shrimp dumplings and scallop crudo, and solicit feedback. Tastings will be held in Aqua’s West Loop, Chicago headquarters beginning in early April. Aqua is developing a range of alt-seafood from proprietary mycoprotein fermentation processes. A unique strain of fungi transforms plant-based ingredients into “seafood” with a realistic taste, texture, and appearance that can be used as a one-to-one replacement for animal seafood. The company is also producing minced fillings for applications such as dumplings, ravioli, and sushi rolls. “Public tasting events will help us fine-tune products and learn what preparations are most successful, which will also help us create new menu items with chef and restaurant partners,” said Aqua CEO Anne Palermo. “Participants should arrive hungry and prepare to be wowed, because they’ve never had plant-based seafood that’s this delicious and this convincing.” Those interested in joining a tasting panel can sign up at https://www.eventbrite.com/e/aqua-customer-taste-panels-tickets-565576212677?aff=Newsletter. Aqua’s calamari, shrimp, scallops, and filets of tuna and whitefish are created using fermentation processes that do not use any animal inputs, genetic altering or modification. Unlike plant-based processed foods formulated with starches and protein isolates, Aqua’s alt-seafood retains its naturally occurring fiber, protein, and other micronutrients. The rising demand for seafood has led to depleted fish populations, ecosystem damage, plastic waste, and unintended “bycatch” of non-target species due to commercial fishing. As fish farming increases, so does habitat destruction, pollution and diseases in wild fish populations, and the industry’s reliance on antibiotics and wild-caught fish for feed. For images visit https://app.box.com/s/wfbrvgraf2ty2b7by5h6ahjsaqrd8zx3. About Aqua Cultured Foods Aqua Cultured Foods is an innovative food technology startup developing the world’s first whole-muscle cut seafood alternatives created through microbial fermentation. Its novel technology produces a sustainable, complete protein source using only a fraction of the resources required by traditional aquaculture. As the first to develop realistic alt-seafood with fermentation, Aqua Cultured Foods occupies a unique position in the burgeoning alt-seafood market, as well as within the fermentation industry. The company’s mission is to mitigate global challenges such as overfishing, climate change and feeding the world’s expanding population with delicious, nutrient-rich foods. For more information visit https://www.aquaculturedfoods.com. Contact Details Evolotus PR Gary Smith +1 818-783-0569 gary@evolotuspr.com Company Website https://www.aquaculturedfoods.com

March 21, 2023 09:30 AM Eastern Daylight Time

Article thumbnail News Release

Axis Medicare Advisors Partners with AmeriLife to Accelerate Growth

AmeriLife

AmeriLife Group, LLC (“AmeriLife”), a national leader in developing, marketing, and distributing life and health insurance, annuities and retirement planning solutions, announced today that it has partnered with Louisville, Ky.-based Axis Medicare Advisors, one of the nation’s top designers and distributors of market-leading Medicare Supplement and ancillary health products for Aetna. Per the agreement, terms of the deal were not disclosed. “Our business was built on ‘trust,’ and today, I’m excited to announce that we, too, have found a trusted partner in AmeriLife to propel Axis forward,” said James “Jamie” Sarno, president and CEO of Axis Medicare Advisors. “Our team is excited to join this industry leader. We look forward to tapping into AmeriLife’s incredible leadership and resources to continue delivering excellence for Axis agents and their clients.” Founded in 1991, Axis has grown from a small outfit into a leading Medicare solutions shop known for its deep Medicare Supplement and ancillary health product portfolio, best-in-class customer service, and expert knowledge of the evolving and complex Medicare space. Now, Axis will have full access to AmeriLife’s best-in-class technology, tools and resources and leading distribution platform, positioning it for significant growth and long-term success. Relatedly, Sarno will join AmeriLife as vice president of Medicare Supplement and Specialty Health and will report to AmeriLife’s Chief Distribution Officer of Health, Scotty Elliott, effective April 3. Sarno brings over 35 years of experience in the Medicare Supplement market to AmeriLife, and as a national advisor for Aetna, he has supported the design of proprietary products that remain core to AmeriLife’s holistic health offering. With Sarno’s departure, Ronnie Lapinsky will assume day-to-day operational oversight of Axis. “Ronnie has been a loyal friend and valuable asset at Axis for more than 21 years,” added Sarno. “There’s no one better suited to continue Axis’s legacy of protecting seniors and helping them with the ever-changing landscape of Medicare.” “We’re thrilled to welcome Axis Medicare Advisors to AmeriLife’s Health family and, at the same time, Jamie to our growing Health leadership bench,” said Elliott. “Both represent the continued, incredible run of growth for our Health distribution. We can’t wait to work with Jamie to elevate our Medicare Supplement and health specialty strategy while also helping Ronnie and his team at Axis expand and grow their business to new heights.” ### About AmeriLife AmeriLife’s strength is its mission: to provide insurance and retirement solutions to help people live longer, healthier lives. In doing so, AmeriLife has become recognized as the leader in developing, marketing, and distributing life and health insurance, annuities and retirement planning solutions to enhance the lives of pre-retirees and retirees across the United States. For more than 50 years, AmeriLife has partnered with top insurance carriers to provide value and quality to customers served through a distribution network of over 300,000 insurance agents and advisors and 120 marketing organizations and insurance agency locations nationwide. For more information, visit AmeriLife.com, and follow AmeriLife on Facebook and LinkedIn. About Axis Medicare Advisors Founded in 1991 and based in Louisville, Ky., Axis Medicare Advisors is a leading Medicare and specialty health insurance agency serving seniors nationwide. Axis’s team of professionals offers unparalleled customer support, expert advice and a portfolio of health solutions from some of the biggest insurance carriers in the market. For more information, visit AxisMedicareAdvisors.com. Contact Details Media Jeff Maldonado +1 321-297-1112 jmaldonado@amerilife.com Partnership Inquiries Patrick Nichols +1 727-726-0726 pnichols@amerilife.com Company Website https://amerilife.com/

March 21, 2023 09:00 AM Eastern Daylight Time

Article thumbnail News Release

2023년 투자하기 좋은 코인 추천 - 코인 전망

Finance News

지난 10년 동안 가상화폐는 우리의 삶 속에 침투해 제3의 중재자 없이 개인과 개인이 커뮤니케이션할 수 있는 탈중앙 인프라를 구축했다. 가상화폐 시장이 끊임없이 진화하고 성장하면서 투자자들은 지금 투자할 수익성 높은 코인을 언제나 찾고 있다. 오늘은 올해 그리고 장기적으로 투자하기 좋은 유망코인에 관해 알아본다. 최초의 가상화폐 프로젝트 비트코인(Bitcoin)이 2009년에 등장한 이후 1만 8,000개 넘는 가상화폐가 출시됐다. 숫자는 계속해서 증가하고 있지만, 과연 모든 자산이 실제로 가치가 있을까? 통상 모든 가상화폐는 크게 두 가지 그룹으로 분류할 수 있다. 첫 번째 유형은 특정 용도를 가지고 개발된 프로젝트로 대체로 디파이(Defi) 산업을 업그레이드한다는 공통의 목적을 가진다. 두 번째 그룹은 투기성 자산으로 사실상 다른 프로젝트의 모방작이면서 재미를 위해 제작된 경우가 많다. 일부는 뛰어난 마케팅 전략으로 압도적 인기를 누리기도 하지만 다른 프로젝트는 아무런 가치가 없기 때문에 단순 실패로 돌아가기도 한다. 투자의 관점에서 첫 번째 그룹에 속하는 가상화폐에 투자하는 것이 위험성이 적고 수익성이 높을 것이다. 이들은 유망한 프로젝트로 만약 개발팀이 실행 계획을 성공적으로 실천한다면 가치가 그에 따라 상승하기 때문이다. 하지만 산업에는 이러한 프로젝트가 셀 수 없이 많다. 어떻게 투자해도 좋은 코인을 선별할 수 있을까? 본 가이드는 2023코인 전망 순위를 통해 지금 당장 투자해도 좋은 코인 전망 순위에 관해 알아본다. 2023년 코인 전망 순위 - 암호화폐 전망 아래에서는 암호화폐 전망에 관해 순위별로 자세히 분석해본다. 이 가이드에 따라 본인의 성향과 관심사에 맞는 가상 자산을 찾아보는 것을 추천한다. 1. 러브 헤이트 이누 - 실용적 사용 사례를 가진 고성장 밈코인 2. 파이트 아웃 - M2E 메카니즘을 사용하는 최첨단 피트니스 코인 3. C+Charge – 친환경 분야 최고의 유망코인 4. 이더리움 - 디앱(dApp) 개발을 위한 가장 유명한 블록체인 5. 스시스왑 - 가상화폐 트레이딩을 위한 AMM 기반 탈중앙화 거래소 6. 컴파운드 - 가상화폐를 대출할 수 있는 탈중앙화 유동성 풀 7. 비트코인 - 시가총액 1위, 세계 최대 가상화폐 8. 유니스왑 - 시가 총액 기준 세계 최대 탈중앙화 코인 거래소(DEX) 9. 샌드박스 - 최고의 메타버스 크립토 및 NFT 게이밍 플랫폼 10. 메이커 - 스마트 계약 기반 디파이 대출 플랫폼 11. 폴리곤 - 디파이 업계에서 가장 빠르게 성장하는 가상화폐 1. 러브 헤이트 이누 - 실용적 사용 사례를 가진 고성장 밈코인 밈코인은 2021년 불장에서 큰 인기를 끌었던 가상화폐 유형이었지만 스캠 프로젝트나 개발팀의 수익 목적으로 개발된 허접한 프로젝트가 대거 등장하며 명성에 금이 갔다. 러브 헤이트 이누 (Love Hate Inu)는 신규 밈코인이지만 탄탄한 펀더멘탈과 혁신적 컨셉을 내세워 빠른 속도로 투자자의 신뢰를 얻고 있다. 비슷한 사용 사례를 제공하는 대부분의 밈코인과 다르게 러브 헤이트 이누는 보트투언(vote-to-earn)이라는 독특한 컨셉을 고안했으며 출시 직후부터 화제가 되고 있다. 프로젝트는 블록체인 기술을 활용해 사용자가 토큰을 스테이킹하여 밈 설문조사에 투표하면 보상을 제공한다. 소셜 미디어는 사회적으로 영향이 큰 만큼 러브 헤이트 이누와 같은 프로젝트는 향후 바이럴 인기를 끌며 대중에게 채택되고 가치가 상승할 것으로 기대된다. 러브 헤이트 이누의 체계적 투표 메카니즘은 사용자에게 정치, 예능, 사회적 문제 등 다양한 주제에 관해 의견을 표현할 기회를 제공하며, 소셜 미디어에서 이미 빠른 속도로 유명세를 타고 있다. 프로젝트는 독특한 블록체인 알고리즘과 익명성 보장 등의 기능을 제공해 기존의 온라인 설문조사 시장에 파괴적 혁신을 가져온다. 현재 프로젝트의 네이티브 토큰 LHINU 사전 판매가 시작했으며 초반부터 높은 투자 수요를 보이고 있다. 하드캡(최대 모집 투자금액)은 1,006만 8,750달러로 설정되어 있으며 관심 있는 투자자는 홈페이지에서 이더리움(ETH), 테더(USDT) 혹은 신용카드를 사용해 토큰을 구매할 수 있다. 개발팀은 전체 토큰 수량의 10%만 플랫폼의 거래소 상장 비용, 커뮤니티 보상, 유동성 확보 등을 위해 준비했으며 나머지 90%를 사전 판매에서 제공하여 인상적이다. 러브 헤이트 이누 의 최신 소식을 확인하려면 트위터 나 텔레그램 등의 소셜 미디어 공식 계정을 참고하는 것을 추천한다. 2. 파이트 아웃 - M2E 메카니즘을 사용하는 최첨단 피트니스 코인 파이트 아웃 (Fight Out)은 독특한 무브투언(move-to-earn) 프로젝트로 사용자가 운동 과제를 완수하면 토큰 보상을 지급한다. 그리고 이 메카니즘 하나만으로 올해 최고의 유망 코인 순위에 올랐다. 파이트 아웃은 무브투언 토큰을 개발해 사람들이 건강한 생활습관을 실천하고 피트니스 메타버스에서 활동할 수 있도록 지원한다. 플랫폼을 사용하기 위해서는 우선 파이트 아웃 앱을 다운로드 받아 계정을 생성해야 한다. 계정을 생성하면 파이트 아웃 메타버스에서 정체성을 형성하는 무료 아바타가 부여된다. 사용자가 현실 세계에서 다양한 운동 목표를 달성하면 메타버스의 디지털 아바타 역시 함께 성장한다. 보상으로 받은 토큰은 아이템 구매, 리그 참여, 전문 코치와의 개인 레슨 등 여러 용도로 사용할 수 있다. 보상으로 지급되는 토큰은 인앱 통화인 REPS이다. 네트워크의 네이티브 토큰 FGHT도 REPS로 교환할 수 있으며 REPS로 아바타를 꾸미는 다양한 NFT 자산을 구매할 수 있다. REPS는 또한 오프라인 파이트 아웃 체육관을 사용할 수 있는 회원권의 성격도 가진다. 프로젝트는 유명 격투기 파이터를 앰배서더로 영입해 프로젝트를 홍보하고 있으며 UFC, MMA 등에 출전하는 선수와 함께 메타버스 속에서 트레이닝할 기회도 주어진다. $FGHT 사전판매의 누적 투자금은 556만 달러를 돌파했으며 아직 거래소 상장 가격에 비해 저렴한 가격에 토큰을 구매할 수 있다. 사전 판매는 3월 31일 종료될 예정이기 때문에 관심 있는 투자자라면 서둘러야 할 수 있다. 3. C+Charge – 친환경 분야 최고의 유망코인 C+Charge 는 친환경 가상화폐에 투자하고 싶은 트레이더에게 2023년 최고의 추천 코인이다. 현재 C+Charge는 네이티브 토큰 CCHG의 사전 판매를 진행하고 있으며 사전 판매 7단계에서 토큰을 $0.02에 판매하고 있다. 5일 후에는 마지막 8단계에 진입하기 때문에 지금이 조금이라도 더 많은 토큰을 확보할 수 있는 절호의 기회이다. CCHG는 C+Charge 생태계를 뒷받침하는 토큰으로 전체 토큰 공급량이 10억 토큰이며 이 중에서 40%가 사전 판매에서 판매된다. 8%의 토큰은 거래소 상장 시 유동성 공급을 위해 배분되었다. C+Charge 생태계의 중심에는 C+Charge 앱이 있으며 앱은 전기차 운전자에게 다양한 혜택을 제공한다. 핵심 기능을 살펴보면: 인근 충전소 위치 탐색 - 앱은 전기차 운전자가 즉시 인근에 위치한 충전소의 위치를 탐색할 수 있도록 도와 미리 여정을 계획할 수 있도록 돕는다. 충전 요금 정보 - 전기차 운전자들은 여전히 충전소에 도착해서야 충전 요금 정보를 알게 된다. 하지만 C+Charge 앱을 사용하면 충전소에 도착하기도 전에 투명하게 요금을 확인하고 비교할 수 있다. 결제 시스템 - C+Charge에는 P2P 결제 시스템이 장착되어 있어 어디서든 쉽고 간편하게 CCHG 토큰을 사용해 충전 요금을 지불할 수 있다. 탄소 배출권 NFT - 사용자는 제휴 충전소에서 CCHG 토큰으로 차량을 충전할 수 있다. 이때 충전에 대한 보상으로 탄소 배출권 NFT를 획득할 수 있다. 프로젝트의 누적 투자금은 300만 달러에 근접하며 3월 31일에 사전 판매가 종료되어 저렴하게 토큰을 구매할 수 있는 날이 얼마 남지 않았다. C+Charge는 올해 최고의 지속가능한 친환경 코인으로 더 자세한 정보는 텔레그램 그룹 이나 백서 에서 확인할 수 있다. 4. 이더리움 - 디앱(dApp) 개발을 위한 가장 유명한 블록체인 이러디움(Ethereum)은 디파이(DeFi) 시장에서 가장 진화한 수익성 높은 코인 중 하나로 가상화폐를 한 번이라도 거래해 본 사람이라면 이름을 들어보았을 것이다. 이더리움은 러시아-캐나다인 프로그래머 비탈릭 부테린(Vitalik Buterin)이 창립했으며 시가 총액이 3,595억 달러로 전 세계 가상화폐 중 2위를 자랑한다. 이더리움은 탈중앙화 애플리케이션(디앱)을 개발하는 데 사용할 수 있는 블록체인 플랫폼으로 다른 수많은 가상화폐 프로젝트의 바탕이 된다. 이더리움은 스마트 계약을 사용한 최초의 플랫폼이다. 스마트 계약은 거래의 일정 조건을 만족시키면 당사자 간에 자동적으로 거래가 체결되는 자동 계약 프로토콜이다. 이더리움은 초기에 작업증명(PoW) 합의 알고리즘으로 배포되었지만 이제 보다 친환경적인 지분증명(PoW) 메카니즘으로 전환하는 과정에 있다. 이더(Ether)는 이더리움 블록체인의 네이티브 가상화폐로 티커 ETH를 사용하며 현재 $1,700 부근에서 거래되고 있다. 세계에서 가장 인기 있는 가상화폐 중 하나인 이더리움은 전 세계 대부분의 가상화폐 거래소와 브로커리지에서 지원한다. 토큰 보유자는 ETH 토큰을 스테이킹하여 네트워크 안전성을 도모하고 보상을 획득할 수 있다. 이더리움은 비트코인이 아닌 가상화폐 중 가장 투자 가치 높은 것으로 평가되며, 최고의 알트코인으로도 불린다. 5. 스시스왑 - 가상화폐 트레이딩을 위한 AMM 기반 탈중앙화 거래소 탈중앙화 앱의 개발과 함께 탈중앙화 코인 거래소(DEX)도 함께 등장하고 있다. DEX는 전통 거래소와 비슷하게 가상화폐의 구매 및 판매를 지원한다. 스시스왑(Sushiswap)은 이더리움 블록체인에서 개발된 탈중앙 코인 거래소 중 하나로, 다른 많은 DEX와 마찬가지로 집합적 유동성 풀을 사용한다. 제3자가 거래를 관리하는 전통 거래소와 달리, 스시스왑에서는 자산이 스마트 계약에 잠겨 있다. 토큰 보유자는 가상화폐를 ‘유동성 풀’에 제공하고 구매자가 토큰을 구매하게 된다. 이러한 메카니즘은 자동화된 마켓 메이커(AMM)라 불리며 중앙 거버넌스 주체 없이 모든 절차가 코드를 통해 처리된다. 스시스왑의 네이티브 토큰 SUSHI는 거버넌스 토큰이다. 즉 SUSHI 토큰을 보유한 사람은 누구나 프로젝트의 운영과 관련하여 개선사항을 제안할 수 있으며 다른 사람의 제안에 대해 투표하는 것도 가능하다. SUSHI는 $1 이하의 가격으로 시장에 데뷔하였다. 일 년도 안 되어 SUSHI 가격은 극적으로 상승하며 2021년 3월 13일 사상 최고가 $22까지 도달한다. 이후 SUSHI 가격은 지속적으로 감소하였으며 창립자 중 한 명의 대량 매도도 영향을 미친 것으로 알려졌다. 현재 SUSHI는 저평가된 상태로 많은 트레이더가 SUSHI를 최고의 수익률을 제공할 추천코인으로 지목하고 있다. 6. 컴파운드 - 가상화폐를 대출할 수 있는 탈중앙화 유동성 풀 컴파운드(Compound, COMP)는 기업가 로버트 레쉬너(Robert Leshner)와 제프리 헤이즈(Geoffrey Hayes)가 창립한 이더리움 기반 가상화폐 프로젝트이다. 프로젝트는 전통 금융 시장을 조성해 사용자가 자금을 대출하고 그에 대해 보상을 받을 수 있도록 지원한다. 반대로 대출자는 시장에서 대출을 받고 금리를 지불하면 된다. 현재 플랫폼은 10개 이상의 가상화폐를 지원하며 이더리움(Ethereum), 다이(DAI), 테더(USDt), USD코인(USDC), 랩트비트코인(Wrapped Bitcoin) 등이 포함된다. 컴파운드는 2017년 스타트업으로 시작하여 2018년에 안드레센 호로위츠(Andreessen Horowitz), 베인 캐피털 벤처스(Bain Capital Ventures) 등의 유명 기업으로부터 820만 달러를 투자 받았다. 이어서 2019년에는 코인베이스(Coinbase), 패러다임 캐피털(Paradigm Capital) 등으로부터 2,500만 달러 가까이 조달했다. 컴파운드는 여러 가상화폐의 대출 기능을 지원하는 것 외에도 자체 토큰 COMP가 존재해 플랫폼 사용자가 컴파운드 네트워크와 상호작용할 때 토큰을 지급한다. COMP 토큰의 최대 공급량은 1,000만 토큰으로 이미 67%가 유통되고 있다. 컴파운드의 시가 총액은 8억 3,600만 달러 이상으로 세계 100대 가상화폐 순위 안에 든다. 7. 비트코인 - 시가총액 1위, 세계 최대 가상화폐 비트코인(Bitcoin)은 세계 최초의 가상화폐로 2009년 사토시 나카모토(Satoshi Nakamoto)라는 별명으로 활동한 개인 혹은 그룹에 의해 창립되었다. 시간이 지남에 따라 비트코인은 큰 인기를 누렸으며 이 과정에서 시가 총액 기준 세계 최대 가상화폐로 성장했다. 비트코인의 성장 이유에는 2,100만 BTC로 제한된 토큰 공급량도 원인으로, 이미 1,900만 토큰 이상이 유통되고 있다. 비트코인은 탈중앙화 결제 시스템을 구축해 전 세계 누구나 익명성을 유지하며 원하는 곳으로 트랜잭션할 수 있도록 지원하는 것을 목표로 한다. 비트코인은 작업증명(PoW) 프로토콜 기반의 블록체인 기술을 사용한다. 비트코인 채굴자가 되기 위해서는 정교한 하드웨어가 필요하며 새로운 블록을 생성하기 위해서는 방대한 양의 전기 에너지가 필요하다. 비트코인 추천 이유 하나는 프로젝트가 산업에서 가장 저명한 코인이기 때문이다. 이미 몇몇 대기업은 BTC 결제를 지원하며 비트코인으로 상품 혹은 서비스를 구매할 수 있다. 다음 이유는 비트코인의 낮은 공급량으로, 향후 비트코인 수요가 증가할 때 가격에 긍정적 영향을 미칠 주요 원인이 된다. 1 BTC를 구매하기에는 자금이 부족하더라도, 일부 조각만 구매할 수 있어 적은 자본금을 투자하는 것도 가능하다. 많은 전문가는 비트코인을 포트폴리오에 견고함을 더해줄 최고의 가상화폐로 평가한다. 수많은 알트코인이 0을 향해 가는 와중에도 비트코인은 언제나 신고점을 경신했다. 8. 유니스왑 - 시가 총액 기준 세계 최대 탈중앙화 코인 거래소(DEX) 유니스왑은 유동성 풀을 통해 탈중앙화 거래소(DEX)를 구축하는 또 하나의 이더리움 기반 프로젝트이다. 유니스왑 플랫폼에는 두 가지 회원군 유동성 공급자(liquidity provider)와 트레이더가 존재한다. 첫 번째 회원군은 자산을 스마트 계약에 잠그며 두 번째 회원군인 트레이더는 이 자산을 구매하고 판매할 수 있다. 매도자와 매수자는 유니스왑에서 거래를 처리하는 대가로 거래 수수료를 지급하며, 이 수수료는 나중에 유동성 공급자에게 UNI 토큰을 지급하는 데 사용된다. 이러한 방법을 통해 전체 과정을 통제하는 제3자 없이도 플랫폼을 운영할 수 있다. 가상화폐 산업에는 여러 DEX 프로젝트가 존재하지만, 유니스왑은 그 중에서도 압도적 관심을 받으며 시가 총액 기준 세계 최대 규모의 탈중앙화 암호화폐 거래소로 성장했다. 유니스왑은 자동 유동성을 제공하기 위해 구축된 최초의 DEX 중 하나이다. 프로젝트는 2018년 헤이든 아담스(Hayden Adams)가 창업했다. 2020년에 플랫폼은 2020년 9월 이전에 한 번이라도 플랫폼에서 거래한 적이 있는 회원에게 400 토큰을 에어드랍했다. 유니스왑 토큰은 거래 수수료 지불 및 유동성 공급자 보상 제공 외에도 거버넌스 토큰으로 역할을 수행해 프로젝트의 중요 안건에 대해 투표할 권리를 나타낸다. 9. 샌드박스 - 최고의 메타버스 크립토 및 NFT 게이밍 플랫폼 샌드박스는 가장 유명한 메타버스 프로젝트 중 하나로, 사용자는 플랫폼에서 NFT 형태의 아바타를 제작하고, 개발하며 샌드박스 마켓플레이스에서 판매해 보상을 획득할 수 있다. 플랫폼은 높은 기능성을 제공해 사용자가 단순히 아바타를 소유할 뿐 아니라 무기, 의류, 악세사리 등을 구매해 장착할 수 있다. 사용자는 또한 플랫폼에서 LAND라고 하는 필지를 소유할 수 있다. LAND는 다양한 아이템으로 업그레이드 가능하며, 토지에서 이벤트를 주최하고 입장료를 받는다거나 다른 사용자에게 임대하여 수익을 창출할 수 있다. 샌드박스 프로젝트는 전체 네트워크를 가동하기 위해 유틸리티 토큰이자 거버넌스 토큰인 SAND을 개발했다. SAND는 거래 수수료, 보상 지급, 스테이킹, 안건 투표 등 다양한 용도로 사용된다. SAND의 시가 총액은 9억 달러에 달하며 시가 총액 기준 전 세계 가상화폐 50위 안에 든다. 10. 메이커 - 스마트 계약 기반 디파이 대출 플랫폼 메이커(Maker) 프로젝트는 초창기 디파이 프로젝트 중 하나로 2015년에 덴마크 창업자 룬 크리스텐슨(Rune Christensen)이 창업했다. 프로젝트는 메이커다오(Maker DAO)와 메이커 프로토콜로 구성된다. 메이커 다오는 메이커 프로토콜을 운영하기 위한 탈중앙화 조직이며 메이커 프로토콜은 사람들이 DAI 코인을 발행할 수 있도록 지원한다. DAI는 USD 페깅 스테이블코인으로 다시 말해 시장 여건에 상관없이 코인 가치가 미국 달러와 동일하게 유지된다. 메이커다오는 거버넌스 토큰 MKR 가상화폐로 구동되며 토큰을 보유한 사람은 누구나 메이커다오 생태계의 소유권을 일부 가진다. 즉 MKR 보유자는 프로젝트의 개발에 참여하고 관련 제안에 투표할 수 있다. MKR 코인은 현재 $716에 거래되고 있으며 시가 총액은 7억 달러에 달한다. 가상화폐의 최대 공급량은 100만 5,577 MRK 코인이며 이미 97%가 유통되고 있다. 11. 폴리곤 - 디파이 업계에서 가장 빠르게 성장하는 가상화폐 폴리곤(Polygon) 프로젝트는 전 세계적으로 유명한 가상화폐로 지난 2년 동안 기록적 상승률을 보여준 코인이다. 하지만 폴리곤이 투자 추천 코인 순위에 오른 이유는 프로젝트의 성장 잠재력 때문이다. 폴리곤 프로젝트는 가장 성장 가능성이 높은 유망한 가상화폐 중 하나로 가상화폐 커뮤니티에 회자되며 거대한 지지 커뮤니티를 보유한다. 폴리곤은 2017년에 매틱 네트워크(Matic Network)로 처음 출시되었다. 얀티 카나니(Jaynti Kanani), 샌딥 네일왈(Sandeep Nailwal), 아누라그 아르준(Anurag Arjun)는 블록체인 업계에서 쌓은 상당한 경력을 바탕으로 폴리곤을 창립해 인도에서 가장 빠르게 성장하는 가상화폐 프로젝트로 성장시켰다. 폴리곤은 최고의 이더리움 확장 및 인프라 개발 이니셔티브가 되는 것을 목표로 한다. 폴리곤의 핵심 구성 요소인 폴리곤 SDK는 유연한 모듈러 프레임워크로 다양한 유형의 애플리케이션을 쉽게 개발할 수 있도록 돕는다. 개발자는 폴리곤을 사용해 옵티미스틱 롤업 체인, ZK 롤업체인, 스탠드- 얼론 체인 등 필요로 하는 모든 종류의 인프라를 개발할 수 있다. 폴리곤은 이더리움을 완전한 멀티 체인 시스템(이른바, 블록체인의 인터넷)으로 변환한다. 폴리곤의 네이티브 토큰 MATIC은 시가 총액 기준 전 세계 10위 안에 들며 2021년 불장에서 최고의 상승률을 자랑한 알트코인 중 하나였다. 투자자들은 다시 상승장이 오면 이러한 흐름이 반복될 것이라 생각하고 크립토 윈터 와중에도 대량으로 MATIC을 매집하고 있다. 폴리곤은 IOU를 거쳤다. IOU 후에 메인넷 출시가 이루어진 코인은 알레오 코인을 포함해 다양하다. IOU는 I Owe You의 약어로 코인의 일정량을 아직 시장에 풀리기 전에 먼저 사고 파는 것을 뜻한다. 폴리곤 외에도 알레오 코인 상장을 비롯해 많은 사람들이 IOU를 거친 코인의 전망을 기대하고 있다. 마치며 가상화폐가 우리 곁에 다가온지 아직 20년도 안 되었으며 따라서 완전히 신뢰할 수 있을 정도로 정립되었다고 할 수 없다. 가상화폐 시장은 높은 변동성을 특징으로 하며 투자금 손실이 발생할 위험성도 크다. 높은 위험성이 수반되는 만큼 가상화폐에 합리적으로 투자할 수 있다면 높은 수익률 또한 기대할 수 있다. 가상화폐에 투자해도 되는 시기인지 분석할 때에는 거시 경제, 정치적 상황 등 다양한 요인을 고려해야 한다. 거래 수준을 높여 투자 성공률을 극대화하기 위해서는 철저한 펀더멘탈 조사 및 시장 분석이 뒷받침되어야 한다. 본 가이드는 2023년 투자하기 좋은 코인추천 순위를 알아보았으며 이제 이 중에서 선호하는 암호화폐 골라 투자하면 된다. 집필진의 추천 코인 1위는 러브 헤이트 이누 이다. LHINU는 독특한 보트투언 토큰으로 올해 성장 잠재력이 매우 높으며 과소평가해서는 안 될 유망코인이다. Contact Details Finance News Alex Brown alex@financenews.com

March 19, 2023 10:51 AM Eastern Daylight Time

Article thumbnail News Release

UAT Group Subsidiary, Ossifix Orthopedics Begins Expansion

Umbra Applied Technologies Group, Inc.

McapMediaWire -- Umbra Applied Technologies Group, Inc. (OTC: UATG ) (UAT Group) announced today that its subsidiary, Ossifix Orthopedics has begun expanding beyond Texas starting with southern and north-eastern part of the United States. Over the past several weeks, the Company has onboarded five new account managers across eleven cities in Texas with expansion into the New England area currently underway. The Company has slated the second fiscal quarter of the year for expansion across four major metropolitan cities in Louisiana and across twenty-one major metropolitan cities in Florida. Ossifix CEO, Mark Estrada, stated: “We are currently in the process of expanding operations and onboarding distribution channels in select target regions. Additionally, in Q2 we will launch two unique foot and ankle product lines.” The Company projects more than one-hundred surgeries to be completed in Q2 alone with a 20% increase month over in growth. Results from initial surgeries have demonstrated early ambulation trend with many patients driving the next day. Results of the surgeries have dramatically increased interest in the Javelin pin which formed the basis for the Company’s decision to start expansion and led to the Company to begin increasing its salesforce. Constructed of select, high-density, allograft, cortical bone, the proprietary design of the Ossifix Orthopedics Javelin pin ensures rigid fixation without pin slip or pirouetting. Manufactured of 100% allograft bone, Ossifix implants are designed for small bone, extremities, and sports medicine markets, but have applications in the craniofacial, spine and oral surgery procedures. Resorbable implant technology is readily accepted and used in today’s market, both domestically and globally. Ossifixs’ unique manufacturing process and designs yield an engineered cortical bone implant that provides secure fixation and virtually eliminates any allergic or autoimmune reactions associated with metal or plastic/polymer implants. All Ossifix Orthopedics Pin, Screw and Plate Systems are single-use surgical kits with all necessary instruments for implantation and are based on decades of clinical experience and use in the operating room. Ossifix products are designed to be used in hospitals, ambulatory surgical centers, and specialty clinics. Distribution is scheduled throughout North America, and globally in Latin America, Europe, Asia Pacific, as well as the Middle East and Africa. This global market is currently experiencing an estimated growth of 14% per year and is expected to reach $4.696 billion in sales this year. Umbra Applied Technologies Group Chief Executive Officer, Alex Umbra, commented, "The growth and interest that Ossifix has experienced is unprecedented. With the launch of their additional product suites coming later this year, Ossifix will be a disrupting force within a niche but significant market segment”. Ossifix Orthopedics will continue to meet with hospital systems, surgical centers and orthopedic surgeons across the U.S. with international sales slated to begin later this year. For more information about Ossifix Technologies go here: https://ossifixtech.com/ About Umbra Applied Technologies Group, Inc. The firm is located in Tampa Florida and focuses on advanced technologies across many disciplines. UAT Group is a holding company with interests in both public and private companies during the early stages of development as well as growth stages of companies with a synergistic business model to UAT Group subsidiaries. For more information, visit: www.uatgroup.com Investor and Media Contact: info@uatgroup.com NEITHER THE SECURITIES EXCHANGE COMMISSION NOR ITS REGULATION SERVICES PROVIDER ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS NEWS RELEASE. Forward-Looking Information This news release may include "forward-looking statements" including forecasts, estimates, expectations, and objectives for future operations including but not limited to its ability to conclude a business combination with a third party, sale of assets, return of capital or initial public offering and a secondary listing on the OTC as a result of aforementioned and its ability to fund the exploration of its assets through the raising of equity or debt capital or through funding by a joint venture partner that are subject to a number of assumptions, risks, and uncertainties, many of which are beyond the control of Umbra Applied Technologies Group including but not limited to capital markets and securities risks and continued development success on technology. There can be and are no actual or implied guarantees that any of the above activities will be completed or completed on terms acceptable to the Company and its shareholders or approved by any regulatory authority having jurisdiction. Such forward-looking information represents management's best judgment based on information currently available. No forward-looking statement can be guaranteed and actual future results may vary materially. Umbra Applied Technologies Group does not assume the obligation to update any forward-looking statement, except as required by applicable law. Contact Details Umbra Applied Technologies Group, Inc. info@uatgroup.com

March 17, 2023 08:00 AM Eastern Daylight Time

Article thumbnail News Release

Jersey Mike’s Subs and the Harlem Globetrotters team up to Launch Nationwide Creativity Competition in U.S. Elementary Schools

Campus Multimedia

Jersey Mike’s Subs today announced they have partnered with the world-famous Harlem Globetrotters to launch a nationwide creativity competition for elementary schools across the United States. Known as the “Court of Creativity presented by Jersey Mike’s Subs,” the contest will award $1,000 to 10 finalists, and one grand prize winner will receive a visit from the Harlem Globetrotters before the end of the 2022-23 school year. School administrators, teachers, PTA representatives, and parents are encouraged to submit a video or photos of their students showcasing their creativity related to the Harlem Globetrotters or the sport of basketball. Options could include a piece of Harlem Globetrotter-inspired art, a musical number, a trick shots video, or incorporating basketball into their favorite subject. To find more information and official rules or submit your entry, visit https://www.courtofcreativity.com/. The competition is underway, and entries will be accepted through April 16th, 2023. “Anytime you interact with the Harlem Globetrotters, you think about what it would be like to spin the ball on your finger, soar through the air for a dunk, shoot from half-court, or make people smile through the sport of basketball,” said Rich Hope, Chief Marketing Officer of Jersey Mike’s Franchise Systems, Inc. “The Court of Creativity is a school’s opportunity to showcase and inspire others. The ball’s in your court to create through art, music, sports, cooking, or more.” “Creativity is an important part of what we do as the Harlem Globetrotters, and we’re excited to provide a platform to foster creative expression in kids with the help of our friends at Jersey Mike’s,” said Keith Dawkins, President of Harlem Globetrotters and Herschend Entertainment Studios “Basketball is a form of creative, and intellectual, expression and this partnership helps us make a deeper impact with kids who are our next generation of leaders.” The contest is open to public, private, or vocational schools with grades Kindergarten through 5th and located in the United States. Submissions can be made by the school administration or the parent or legal guardian of a child that is currently enrolled in an elementary school. When submitting an entry, social posts must feature the hashtag #CourtofCreativityContest, followed by completing the online form at https://www.courtofcreativity.com/enter. ABOUT JERSEY MIKE’S SUBS Jersey Mike’s Subs, with nearly 2,500 locations nationwide, serves authentic fresh sliced/fresh grilled subs on in-store freshly baked bread — the same recipe it started with in 1956. Passion for giving in Jersey Mike’s local communities is reflected in its mission statement “Giving…making a difference in someone’s life.” For more information, please visit jerseymikes.com or follow us on Facebook (facebook.com/jerseymikes), Instagram (instagram.com/jerseymikes), and Twitter (twitter.com/jerseymikes.com). ABOUT THE HARLEM GLOBETROTTERS The World-Famous Harlem Globetrotters are THE originators of basketball style, captured by dynamic athletes with unmatched skills and influencers of today’s game. The team has showcased their iconic brand of basketball in over 124 countries and territories across six continents since 1926. Proud inductees into the Naismith Memorial Basketball Hall of Fame, their mission continues to advance the game of basketball and deliver exciting and interactive entertainment to the world. If you have ever seen a jump shot, slam dunk or a half-court hook shot, you have witnessed the creative moves made famous by the Globetrotters.The Harlem Globetrotters International, Inc. is a subsidiary of Herschend Enterprises, the largest family-owned themed entertainment company in the U.S. Contact Details Eric Nemeth nemeth@ericpr.com Company Website https://www.campusmultimedia.com/

March 16, 2023 10:42 AM Eastern Daylight Time

1 ... 7980818283 ... 240